New Market Research Report "Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2013" Has Been Added In MarketResearchReports.Biz's Reports Database
Albany, NY -- (SBWIRE) -- 05/09/2013 -- This is the latest and most up-to-date Market Report from Select Biosciences addressing the CTC and CSCmarkets as they are evolving. In this report, we focus upon technical and business trends in these spaces as they are fast evolving.
CTCs have been shown to have prognostic value in a number of cancer types and therefore there is extensive research and development activity to develop methodologies for CTC enumeration as well as analysis. Furthermore, there is a lot of clinical trial activity in a number of different cancer classes seeking to establish the clinical utility of CTC measurements in various cancer subtypes.
To Read the Complete Report with TOC Visit:http://www.marketresearchreports.biz/analysis-details/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-2013-market-report
Select Biosciences has performed worldwide market tracking wherein we’ve analyzed research trends in the study of CTCs and CSCs. Qualitative and quantitative analysis of product vendors and their market penetrance, markers utilized for the capture/study of CTCs and CSCs as well as cancer classes wherein there is current research activity vis-à-vis CTCs and CSCs are described in this dataset derived from worldwide pools of researchers in November and December 2012—therefore these data reflect the current market landscape
Select Biosciences has also performed extensive analysis of the various clinical trials where CTCs are being enumerated and analyzed. These clinical data set the trajectory of the clinical utility of CTCs
This data-driven characterization of the CTCs and CSCslandscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans—this Market Report is written and delivered to customers in Microsoft PowerPoint format.
Extensive Technical andMarket Analyses
Presented in this Report
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/157625
Molecular Characterization of CTCs and CSCs
Technologies for Studying CTCs
CTC Analysis Workflow
Enrichment and Analysis Methodologies
Details of Selected Approaches for CTC Enumeration and Analysis
Name of Company/Institution
CTC and CSC Research Market Landscape
Bottom-up Market Survey Data: Qualitative and Quantitative Market Analysis
Product Vendors and their Penetrance into the Research Market
Methodologies for Studying CTCs and CSCs
Markers for Characterizing CTCs and CSCs
Downstream Analyses on Captured CTCs
CTC Quantitative Market Metrics
Revenues from Clinical Utilization—Market Size, Market Forecast, Growth Rate
Analysis of Clinical Utility of CTCs
Evidence for Biomarker Utility of CTCs
CTC and CSC Clinical Trials Analysis
MicroRNAs and Exosomes Market Report 2012 : http://www.marketresearchreports.biz/analysis/130635
This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomesmarkets as they are evolving. In this report, we focus upon the microRNA research marketplace from the perspective of the translational opportunities in these spaces. The focus of this field is moving from basic research towards the utility of associations of microRNA expression patterns in disease. In this manner, microRNA signatures may be validated as biomarkers in many disease areas—cancers, cardiovascular disease, neurological disease, inflammation, and metabolic diseases.
Select Biosciences has performed worldwide market tracking wherein we’ve analyzed end-user research trends in the microRNA as well as Exosome markets—these areas are evolving in parallel given the opportunity in the Circulating Biomarkers space and the utility of microRNAs and mRNAs to be harvested from exosomes and assayed as signatures for disease.
For exosomes, we’ve analyzed the research trends, types of downstream applications being performed as well as biomarker classes being studied currently and this is the First Market Report to Document the Market Landscape of Exosomes.
Latest Report :
Cellular Therapy and Cord Blood 2013 Market Report : http://www.marketresearchreports.biz/analysis/160812
This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences. In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space.
We've analyzed clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization. We also present the breakout of clinical trials in the bona fide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948